Diabetes mellitus is common in Hong Kong as well as the rest of the world. A proportional of the patients has kidney involvement and it is called diabetic nephropathy. Some of the patients will go into end stage renal failure requiring dialysis or transplantation. Early detection, control of blood sugar, control of blood pressure and blood lipid control is the key in the management. In Hong Kong, at least 46% of the patients on dialysis is due to diabetic nephropathy.
In the year 2016, the Hong Kong Nephrology will conduct a Diabetic Nephropathy Action Project (the ‘Miyako Project) with the aim to tackle this situation. The scheme will include the upgrading of the clinical apps to assist doctors in treating this condition, lectures to doctors (CME) throughout Hong Kong and the organize a Diabetic Kidney Camp.
Management of diabetic nephropathy with clinical decision support
Diabetic nephropathy is the commonest cause of end-stage kidney failure in Hong Kong. It is caused by long-standing diabetes mellitus.
Treatment of the condition is difficult because the drug usage depends on the eGFR which is difficult to calculate. To solve this problem, Dr Ho Chung Ping developed an ipad and iphone application to help the doctors to manage diabetic nephropathy.
This clinical decision support tool is the first of its kind and can be downloaded at Apple Store for free use by doctors and health care providers at https://itunes.apple.com/app/id623699207
